Impax Laboratories Inc (NASDAQ:IPXL)

46.67
Delayed Data
As of May 28
 +0.56 / +1.21%
Today’s Change
22.12
Today|||52-Week Range
52.10
+47.32%
Year-to-Date
No recent news for Impax Laboratories Inc.

Today’s Trading

Previous close46.11
Today’s open46.07
Day’s range45.65 - 46.85
Volume687,425
Average volume (3 months)715,213
Market cap$3.3B
Dividend yield--
Data as of 3:59pm ET, 05/28/2015

Growth & Valuation

Earnings growth (last year)-44.90%
Earnings growth (this year)+2.24%
Earnings growth (next 5 years)+26.41%
Revenue growth (last year)+16.53%
P/E ratio73.6
Price/Sales3.62
Price/Book3.70

Competitors

 Today’s
change
Today’s
% change
CLVSClovis Oncology Inc-3.20-3.41%
RAREUltragenyx Pharmaceu...+1.32+1.52%
WXWuXi PharmaTech (Cay...+0.39+0.91%
ANACAnacor Pharmaceutica...+0.74+1.07%
Data as of 4:02pm ET, 05/28/2015

Financials

Next reporting dateAugust 4, 2015
EPS forecast (this quarter)$0.37
Annual revenue (last year)$596.0M
Annual profit (last year)$57.4M
Net profit margin9.62%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
George Frederick Wilkinson
Senior Vice President-
Global Operations
Andrew Schaschl
Corporate headquarters
Hayward, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers